GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(40823)

  • GC79832 structure
    GC79832HBpep-K
    Purity: >99.00%

    HBpep-K is a peptide that can form co aggregated droplets.

  • GC79833 structure
    GC79833L-Isoleucic acid
    CAS: 51576-04-6
    Purity: >98.00%

    L-Isoleucic acid ((2S,3S)-2-Hydroxy-3-methylpentanoic acid) ((S)-isoleucic acid) is a non-proteinogenic amino acid derivative.

  • GC79834 structure
    GC79834GGFG-Exatecan TFA
    CAS: 223537-11-9
    Purity: >98.00%

    GGFG-Exatecan TFA is a synthetic intermediate for drug-linker conjugates used in antibody-drug conjugates (ADCs).

  • GC79835 structure
    GC79835L-Phenylalanyl-L-glutamic acid TFA
    Purity: >99.50%

    L-Phenylalanyl-L-glutamic acid TFA (H-Phe-Glu-OH TFA) is a dipeptide present in the exudates of alfalfa seedlings, which exhibits high affinity for PEPT2.

  • GC79836 structure
    GC79836(S)-NH2-NODAGA hydrochloride
    Purity: >99.50%

    (S)-NH2-NODAGA hydrochloride is the S isomer of NH2-NODAGA hydrochloride.

  • GC79837 structure
    GC79837Cys-MC-GGFG-Dxd-d 5
    Purity: >98.00%

    Cys-MC-GGFG-Dxd -d 5 is the deuterium labeled Cys-MC-GGFG-Dxd.

  • GC79838 structure
    GC79838Cys-MC-GGFG-Dxd-d5 TFA
    Purity: >98.00%

    Cys-MC-GGFG-Dxd -d5 TFA (Cys-MC-GGFG-Dxd-d 5 TFA) is the deuterium labeled Cys-MC-GGFG-Dxd.

  • GC79839 structure
    GC79839Aldoview
    CAS: 1356479-94-1
    Purity: >99.00%

    AldoView (Compound 3) is an intermediate.

  • GC79840 structure
    GC79840Cefixime- 13 C, 15 N 2
    Purity: >98.00%

    Cefixime - 13 C, 15 N 2 (FR-17027- 13 C, 15 N 2 ) is the 13 C- and 15 N-labeled Cefixime.

  • GC79841 structure
    GC79841Daptomycin-d 5 TFA
    Purity: >97.00%

    Daptomycin-d 5 (LY146032-d 5 ) TFA is the deuterium labeled Daptomycin TFA.

  • GC79842 structure
    GC79842Citric acid-d 4 trisodium
    CAS: 2704-20-3
    Purity: >98.00%

    Citric acid-d 4 trisodium (Sodium citrate-d 4 ) is the deuterium labeled Citric acid trisodium.

  • GC79843 structure
    GC79843Dihydromyrcenol
    CAS: 18479-58-8
    Purity: >99.50%

    Dihydromyrcenol is an orally active flavor ingredient and Antifungal agent.

  • GC79844 structure
    GC79844NHS-PEG2000-Mannose
    Purity: >98.00%

    NHS-PEG2000-Mannose is an NHS-PEG-Mannose containing PEG2000.

  • GC79845 structure
    GC798454-Propylcatechol
    CAS: 2525-02-2
    Purity: >99.50%

    4-Propylcatechol is an Allylpyrocatechol analog.

  • GC79846 structure
    GC79846Cyclomarin monomer-2
    Purity: >97.00%

    Cyclomarin monomer-2 (Compound 10), a cyclomarin monomer, is a pre-dimerization precursor that can form Homo-BacPROTACs targeting the degradation of ClpC1.

  • GC79847 structure
    GC79847Cyclomarin monomer-1
    Purity: >97.50%

    Cyclomarin monomer-1 (Compound 5), a cyclomarin monomer, is a pre-dimerization precursor that can form Homo-BacPROTACs targeting the degradation of ClpC1.

  • GC79848 structure
    GC79848Episterol
    CAS: 474-68-0
    Purity: >98.00%

    Episterol is an Ergosterol biosynthetic intermediate.

  • GC79849 structure
    GC79849(E)-Antibacterial agent 224
    CAS: 84889-00-9
    Purity: >98.00%

    (E)-Antibacterial agent 224 is an isomer of Antibacterial agent 224.

  • GC79850 structure
    GC79850rac-TNT-i
    Purity: >98.00%

    rac-TNT-i (rac-NPD3064) is the racomer of TNT-i.

  • GC79851 structure
    GC798518,9-Z-Abamectin B1a
    CAS: 113665-89-7
    Purity: >98.00%

    8,9-Z-Abamectin B1a is the 8,9-Z-isomer of Abamectin B1a.

  • GC79852 structure
    GC79852(R,S)-STT3A/B-IN-1
    CAS: 3067185-00-3
    Purity: >99.00%

    (R,S)-STT3A/B-IN-1 (compound 32), the racemate of STT3A/B-IN-1, is a STT3A/B inhibitor.

  • GC79853 structure
    GC79853FITC-D-Glucose
    Purity: >98.00%

    FITC-D-Glucose is a fluorescently labeled glucose derivative and an orally effective bacterial metabolic activity detection probe.

  • GC79854 structure
    GC79854sCy5DA
    Purity: >98.00%

    sCy5DA is a is a fluorescent D-amino acid.

  • GC79855 structure
    GC79855Manogepix-d 4
    Purity: >98.50%

    Manogepix -d 4 (E1210-d 4 ) is the deuterium labeled Manogepix.